{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:31:45Z","timestamp":1740162705086,"version":"3.37.3"},"reference-count":39,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002243"],"award-info":[{"award-number":["UL1 TR002243"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Antibiotics are time-critical in the management of sepsis. When infectious organisms are unknown, patients are treated with empiric antibiotics to include coverage for gram-negative organisms, such as antipseudomonal cephalosporins and penicillins. However, in observational studies, some antipseudomonal cephalosporins (eg, cefepime) are associated with neurologic dysfunction while the most common antipseudomonal penicillin (piperacillin\u2013tazobactam) is associated with acute kidney injury (AKI). No randomised control trials have compared these regimens. This manuscript describes the protocol and analysis plan for a trial designed to compare the effects of antipseudomonal cephalosporins and antipseudomonal penicillins among acutely ill patients receiving empiric antibiotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The Antibiotic Choice On ReNal outcomes trial is a prospective, single-centre, non-blinded randomised trial being conducted at Vanderbilt University Medical Center. The trial will enrol 2500 acutely ill adults receiving gram-negative coverage for treatment of infection. Eligible patients are randomised 1:1 to receive cefepime or piperacillin\u2013tazobactam on first order entry of a broad-spectrum antibiotic covering gram-negative organisms. The primary outcome is the highest stage of AKI and death occurring between enrolment and 14 days after enrolment. This will be compared between patients randomised to cefepime and randomised to piperacillin\u2013tazobactam using an unadjusted proportional odds regression model. The secondary outcomes are major adverse kidney events through day 14 and number of days alive and free of delirium and coma in 14 days after enrolment. Enrolment began on 10 November 2021 and is expected to be completed in December 2022.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The trial was approved by the Vanderbilt University Medical Center institutional review board (IRB#210591) with a waiver of informed consent. Results will be submitted to a peer-reviewed journal and presented at scientific conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05094154\">NCT05094154<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-066995","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:56:54Z","timestamp":1683111414000},"page":"e066995","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Protocol and statistical analysis plan for the Antibiotic Choice On ReNal outcomes (ACORN) randomised clinical trial"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05094154","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05094154","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-3533","authenticated-orcid":false,"given":"Edward Tang","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Siemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Lynn","family":"Dear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Stollings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley Daniel","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward D","family":"Siew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Wrenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Andereck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley H","family":"Self","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7664-8263","authenticated-orcid":false,"given":"Matthew W","family":"Semler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd W","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.1","DOI":"10.1007\/s00134-017-4683-6"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.2","DOI":"10.1016\/j.mcna.2013.02.006"},{"doi-asserted-by":"crossref","unstructured":"Chanderraj R , Baker JM , Kay SG , et al . In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J 2023;61:2200910. doi:10.1183\/13993003.00910-2022","key":"2023050303493021000_13.3.e066995.3","DOI":"10.1183\/13993003.00910-2022"},{"key":"2023050303493021000_13.3.e066995.4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa2114464","article-title":"Balanced multielectrolyte solution versus saline in critically ill adults","volume":"386","author":"Finfer","year":"2022","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.5","DOI":"10.1086\/655131"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.6","DOI":"10.1016\/S1473-3099(07)70109-3"},{"doi-asserted-by":"crossref","unstructured":"Ross RC , Rosen AN , Tran KK , et al . A comparison between cefepime and piperacillin-tazobactam in the management of septic shock. Cureus 2021;13:e18742. doi:10.7759\/cureus.18742","key":"2023050303493021000_13.3.e066995.7","DOI":"10.7759\/cureus.18742"},{"key":"2023050303493021000_13.3.e066995.8","doi-asserted-by":"crossref","first-page":"e1579","DOI":"10.1093\/cid\/ciaa1902","article-title":"Risk of acute kidney injury and clostridioides difficile infection with piperacillin\/tazobactam, cefepime, and meropenem with or without vancomycin","volume":"73","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.9","DOI":"10.1186\/s40780-019-0142-6"},{"doi-asserted-by":"crossref","unstructured":"Blevins AM , Lashinsky JN , McCammon C , et al . Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem. Antimicrob Agents Chemother 2019;63:e02658-18. doi:10.1128\/AAC.02658-18","key":"2023050303493021000_13.3.e066995.10","DOI":"10.1128\/AAC.02658-18"},{"key":"2023050303493021000_13.3.e066995.11","doi-asserted-by":"crossref","first-page":"106010","DOI":"10.1016\/j.ijantimicag.2020.106010","article-title":"Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: a retrospective cohort study","volume":"56","author":"O\u2019Callaghan","year":"2020","journal-title":"Int J Antimicrob Agents"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.12","DOI":"10.1093\/jac\/dkz520"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.13","DOI":"10.1016\/j.jcrc.2018.08.007"},{"key":"2023050303493021000_13.3.e066995.14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciy724","article-title":"Incidence of acute kidney injury among critically ill patients with brief empiric use of antipseudomonal \u03b2-lactams with vancomycin","volume":"68","author":"Schreier","year":"2019","journal-title":"Clin Infect Dis"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.15","DOI":"10.1159\/000337487"},{"key":"2023050303493021000_13.3.e066995.16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"2023050303493021000_13.3.e066995.17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"Balanced crystalloids versus saline in noncritically ill adults","volume":"378","author":"Self","year":"2018","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.18","DOI":"10.1097\/MCC.0000000000000356"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.19","DOI":"10.1007\/s00134-015-3934-7"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.20","DOI":"10.1345\/aph.1D322"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.21","DOI":"10.1097\/PTS.0000000000000225"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.22","DOI":"10.1517\/14740338.7.4.377"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.23","DOI":"10.1097\/CCM.0000000000003349"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.24","DOI":"10.1056\/NEJMoa1301372"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.25","DOI":"10.1097\/CCM.0b013e3181e47be1"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.26","DOI":"10.1016\/j.cmi.2019.06.028"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.27","DOI":"10.1001\/jama.2017.13836"},{"doi-asserted-by":"crossref","unstructured":"Chan A-W , Tetzlaff JM , G\u00f8tzsche PC , et al . Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. doi:10.1136\/bmj.e7586","key":"2023050303493021000_13.3.e066995.28","DOI":"10.1136\/bmj.e7586"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.29","DOI":"10.1097\/ACM.0000000000004021"},{"key":"2023050303493021000_13.3.e066995.30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamainternmed.2022.1070","article-title":"Assessment of awake prone positioning in hospitalized adults with COVID-19: a nonrandomized controlled trial","volume":"182","author":"Qian","year":"2022","journal-title":"JAMA Intern Med"},{"doi-asserted-by":"crossref","unstructured":"Hasselblad M , Morrison J , Kleinpell R , et al . Promoting patient and nurse safety: testing a behavioural health intervention in a learning healthcare system: results of the DEMEANOR pragmatic, cluster, cross-over trial. BMJ Open Qual 2022;11:e001315. doi:10.1136\/bmjoq-2020-001315","key":"2023050303493021000_13.3.e066995.31","DOI":"10.1136\/bmjoq-2020-001315"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.32","DOI":"10.1001\/jama.2016.0287"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.33","DOI":"10.1164\/rccm.201310-1875OC"},{"doi-asserted-by":"crossref","unstructured":"Kidney disease improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2. doi:10.1038\/kisup.2012.1","key":"2023050303493021000_13.3.e066995.34","DOI":"10.1038\/kisup.2012.1"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.35","DOI":"10.1093\/ndt\/gfp766"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.36","DOI":"10.1001\/jama.286.21.2703"},{"doi-asserted-by":"publisher","key":"2023050303493021000_13.3.e066995.37","DOI":"10.1164\/rccm.2107138"},{"unstructured":"Team Rs . RStudio: integrated development for R [RStudio]. Boston, MA: Inc. n.d. Available: www.rstudio.com\/","key":"2023050303493021000_13.3.e066995.38"},{"key":"2023050303493021000_13.3.e066995.39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-066995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:57:16Z","timestamp":1683111436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-066995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,10]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/bmjopen-2022-066995"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-066995","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}